Management of Positive Blood Culture for MRSE
In a patient with positive blood cultures for MRSE (methicillin-resistant Staphylococcus epidermidis) drawn simultaneously from uncertain sites without an indwelling catheter, this most likely represents contamination and does not warrant antibiotic therapy.
Interpretation Framework
The key to managing this scenario lies in distinguishing true bacteremia from contamination using established CDC and IDSA criteria.
Evidence Supporting Contamination
Multiple guidelines explicitly address this exact clinical scenario:
CDC criteria state that common skin contaminants (including coagulase-negative staphylococci like S. epidermidis) cultured from two or more blood cultures drawn on separate occasions are required to meet criteria for laboratory-confirmed BSI 1.
The 1995 HICPAC guidelines specifically recommend against vancomycin treatment in response to a single blood culture positive for coagulase-negative staphylococcus if other blood cultures taken during the same time frame are negative 2.
Since your cultures were drawn simultaneously (not on separate occasions) and from uncertain sites (possibly the same arm), this fails to meet the diagnostic threshold for true bacteremia 1.
Critical Diagnostic Criteria
For MRSE to represent true infection rather than contamination, at least one of the following must be present 1:
- Two or more blood cultures drawn on separate occasions showing the same organism
- Clinical manifestations of infection (fever >100.4°F, chills, hypotension) PLUS the physician institutes appropriate antimicrobial therapy based on clinical judgment
- No indwelling catheter present (which you've confirmed) makes catheter-related BSI impossible
Recommended Management Algorithm
Step 1: Clinical Assessment
Evaluate for signs/symptoms suggesting true infection:
- Fever, chills, or hypotension
- Source of infection (endocarditis, prosthetic device, recent surgery)
- Immunocompromised state
- Recent hospitalization or antimicrobial therapy (risk factors for MRSE colonization) 3
Step 2: Blood Culture Review
- How many bottles are positive? If only 1-2 bottles from the same draw = likely contaminant
- Time to positivity: MRSE-BSI typically shows positivity around 19-27 hours 4. Longer times (>40 hours) suggest contamination 5
- Were cultures drawn from different anatomic sites? Same-site draws increase contamination risk 6, 7
Step 3: Decision Point
If patient is clinically well without signs of infection:
- Do NOT initiate vancomycin or other antibiotics 2
- Repeat blood cultures from two separate peripheral venipuncture sites if clinical concern persists 6, 7
- Observe for 24-48 hours
If patient has clinical signs of infection:
- Obtain repeat blood cultures from two separate sites before starting antibiotics 6, 7
- Consider empiric therapy only if sepsis criteria are met
- Reassess when repeat cultures result
Important Caveats
Common Pitfalls to Avoid
Overtreatment of contaminants: The 2023 IDSA/SCCM guidelines emphasize that contamination is likely if only a single blood culture set is positive for a common skin commensal like S. epidermidis 6. Unnecessary vancomycin contributes to resistance.
Inadequate initial collection: Your scenario highlights a collection error—cultures should be drawn from at least two different anatomic sites 6, 7. Drawing from the same arm (or worse, same site) undermines interpretation.
Volume matters: Each blood culture set should contain 20-30 mL total (10 mL per bottle) 7. Underfilled bottles reduce sensitivity 8.
When MRSE Represents True Infection
MRSE can cause genuine bloodstream infections, particularly in patients with 9, 3:
- Prosthetic devices (cardiac valves, vascular grafts, orthopedic hardware)
- Central venous catheters (though you've excluded this)
- Immunosuppression
- Recent hospitalization with prior antibiotic exposure
In these high-risk patients, even a single positive culture warrants closer scrutiny and possible treatment 1.
Bottom Line
Without clinical signs of infection, no indwelling catheter, and blood cultures drawn simultaneously from uncertain/same sites, treat this as contamination. Do not start antibiotics 2. If clinical concern exists, repeat blood cultures properly (two sets from different peripheral sites) before making treatment decisions 6, 7. The 2008 IDSA/SCCM guidelines are clear: paired blood cultures from separate sites provide the information needed to distinguish true bacteremia from contamination 7.